Skip to content

13F-HR filed by NEA Management Company, LLC

NEA Management Company, LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-10, with 57 holding rows worth $1,779,485,386.

Accession
0001012975-23-000071
Filed
2023-02-10
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2022

A holdings report, 57 entries on the cover page, a total value of $1,779,485,386 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,779,485,386 with VALUE read as dollars as filed, 13F file number 028-14302. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
COURSERA INC COM22266M104Stock15,867,769$187,715,707dollars as filed
ARCELLX INC COMMON STOCK03940C100Stock4,745,262$147,008,217dollars as filed
VERONA PHARMA PLC925050106SPONSORED ADS5,584,753$145,929,596dollars as filed
RHYTHM PHARMACEUTICALS INC76243J105COM4,909,956$142,977,919dollars as filed
BRIGHT HEALTH GROUP INC10920V107COM218,153,623$141,778,040dollars as filed
CLOUDFLARE INC CL A COM18915M107Stock1,873,823$84,715,538dollars as filed
MIRUM PHARMACEUTICALS INC604749101COM4,186,243$81,631,739dollars as filed
ZEROFOX HLDGS INC98955G103COMMON18,068,513$80,983,075dollars as filed
OYSTER POINT PHARMA INC69242L106COMMON STOCK5,925,287$66,185,456dollars as filed
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock1,587,854$64,546,265dollars as filed
MONTE ROSA THERAPEUTICS INC61225M102COM7,692,298$58,538,388dollars as filed
ALLAKOS INC01671P100COM6,147,260$51,759,929dollars as filed
IONQ INC COM46222L108Stock14,614,829$50,421,160dollars as filed
CVRX INC126638105COMMON STOCK2,370,542$43,499,446dollars as filed
GERON CORP374163103COM16,318,681$39,491,208dollars as filed
SAVARA INC805111101COM24,137,931$37,413,793dollars as filed
GLYCOMIMETICS INC38000Q102COM8,967,706$27,172,149dollars as filed
ADAPTIMMUNE THERAPEUTICS PLC00653A107SPONDS ADR17,079,779$24,936,476dollars as filed
NEXTNAV INC65345N106COMMON STOCK8,189,156$23,994,227dollars as filed
BERKSHIRE GREY INC084656107COM38,183,023$23,058,728dollars as filed
CTI BIOPHARMA CORP12648L601COM3,685,683$22,150,955dollars as filed
TREVI THERAPEUTICS INC COM89532M101Stock11,373,174$21,950,226dollars as filed
NKARTA INC65487U108COMMON STOCK3,568,781$21,376,998dollars as filed
DESKTOP METAL INC25058X105COM CL A14,398,927$19,582,541dollars as filed
CELCUITY INC15102K100COM1,250,001$17,512,514dollars as filed
AURINIA PHARMACEUTICALS INC COM05156V102Stock3,969,834$17,149,683dollars as filed
X4 Pharmaceuticals, Inc.98420X103COM11,736,793$11,654,635dollars as filed
RENEO PHARMACEUTICALS INC75974E103COM4,785,494$11,150,201dollars as filed
BUZZFEED INC CL A NEW12430A102Stock15,333,892$10,574,252dollars as filed
FiscalNote Holdings Inc337655104Common Stock1,694,323$9,652,558dollars as filed
Tuya Inc90114C107COM4,934,640$9,425,162dollars as filed
CHAMPIONS ONCOLOGY INC15870P307COM NEW1,713,720$7,728,877dollars as filed
GOSSAMER BIO INC COM38341P102Stock3,467,406$7,524,271dollars as filed
INVENTIVA SA46124U107ADS1,462,586$7,004,324dollars as filed
BILL HOLDINGS INC090043100COM66,070$6,839,038dollars as filed
BLACK DIAMOND THERAPEUTICS I09203E105COM3,448,757$6,207,763dollars as filed
AFFIMED N VN01045108COM4,426,488$5,488,845dollars as filed
Senti Biosciences, Inc.81726A100Common Stock4,426,151$5,345,198dollars as filed
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK2,382,286$4,550,166dollars as filed
ACRIVON THERAPEUTICS INC004890109CMN481,677$4,439,135dollars as filed
XERIS BIOPHARMA HOLDINGS INC98422E103COM3,246,785$4,318,224dollars as filed
SYNLOGIC INC87166L100COM4,228,940$3,213,994dollars as filed
MARKER THERAPEUTICS INC57055L107COM10,714,285$2,848,918dollars as filed
SATSUMA PHARMACEUTICALS INC80405P107COM2,992,958$2,693,662dollars as filed
EARGO INC270087109COM4,520,198$2,599,114dollars as filed
INOZYME PHARMA INC45790W108COM2,437,689$2,559,573dollars as filed
MINERVA SURGICAL INC60343F106COM9,999,125$2,233,805dollars as filed
MEI PHARMA INC55279B202COM NEW8,533,072$2,078,656dollars as filed
REGULUS THERAPEUTICS INC75915K200COM NEW1,445,114$1,979,806dollars as filed
AIRSPAN NETWORKS HOLDINGS IN00951K104COM1,382,300$1,810,813dollars as filed
WHEELS UP EXPERIENCE I F96328L106Com1,061,259$1,093,097dollars as filed
ObsEva SAH5861P103COM4,586,563$665,052dollars as filed
AKARI THERAPEUTICS PLC00972G108ADR452,167$212,473dollars as filed
ADDEX THERAPEUTICS LTD00654J107SPONSORED ADS1,080,000$113,418dollars as filed
AIRSPAN NETWORKS HOLDINGS IN00951K146*W EXP 11/01/20269,928$212dollars as filed
AIRSPAN NETWORKS HOLDINGS IN00951K138*W EXP 08/13/20269,928$110dollars as filed
AIRSPAN NETWORKS HOLDINGS IN00951K120*W EXP 08/13/20269,928$61dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001012975-23-000071this filing2023-02-10acceptance time not in the bulk data set